Skip to content

An Enhanced Home-Based Telemedicine Program Using Remote Examination Devices for Children With Medical Complexity

An Enhanced Home-Based Telemedicine Program Using Remote Examination Devices for Children With Medical Complexity Receiving Comprehensive Care: a Single-Center Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05408143
Enrollment
254
Registered
2022-06-07
Start date
2022-07-12
Completion date
2024-08-26
Last updated
2026-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Diseases in Children

Keywords

Comprehensive Care, Telemedicine enhanced with TytoCare devices., Telemedicine, children with medical complexity

Brief summary

The purpose of this study is to assess if the benefits for children with medical complexity (CMC) receiving comprehensive care (CC) in an enhanced medical home can be further improved by enhanced telemedicine program (ETM) provided during clinic hours using mobile devices to measure temperature and oxygen saturation, auscultate the heart & lungs, and view the skin, throat, and tympanic membranes in the home.

Interventions

OTHERComprehensive care (CC) program

To promote prompt effective care for medically complex children at all hours, the investigators developed an outpatient comprehensive care (CC) program at the University of Texas Health Science Center at Houston, which includes 1) a clinic component with both specialist and primary care in the same clinic, 24/7 direct cell phone access to PCPs at all hours, same weekday care for acute illnesses, and a high staff-to-patient-ratio; 2) a hospital component with consultation service provided by PCPs to help optimize treatment, assure ED physicians and hospitalists are well informed, and coordinate discharge planning; and 3) a conventional telemedicine (CTM) program during regular clinic hours to respond to calls from parents seeking medical advice, to evaluate and recommend treatment for minor illnesses, to schedule a clinic visit if an in-person assessment is needed and to conduct appropriate follow-up visits.

DEVICEEnhanced telemedicine (ETM)

An enhanced telemedicine program (using the HIPAA-compliant, mobile TytoCare exam kit device) will be added to CC to allow providers to remotely visualize the skin, throat, \& ears, auscultate the heart \& lungs, and measure illnesses during clinic hours and chronic illnesses during the detailed patient evaluation to be conducted at least every 6 months by "virtual patient rounds" in the home. These visits will involve the parent(s), the primary care physician (PCP), and if needed, any of 10 specialists, particularly pulmonology, gastroenterology, neurology, and physical medicine and rehabilitation. A social worker, nutritionist, or psychologist will be involved as needed. Each PCP will perform 2-3 virtual patient rounds per week to proactively identify medical problems, suboptimal adherence to treatment, dosing errors, or other problems and intervene before CMC develop a serious illness or require avoidable clinic visits, Emergency Department visits, or hospitalizations.

Sponsors

The University of Texas Health Science Center, Houston
Lead SponsorOTHER
The Systems and Policy Research Network
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Greater than or equal to 2 hospitalizations or greater than or equal to 1 ICU admission in the year before joining the comprehensive care program * Greater than 50 percent estimated risk of hospitalization without our care as judged by the medical director

Exclusion criteria

* Major heart disease * Mitochondrial disorders * Active cancer * Do-Not-Resuscitate (DNR) order * Patients receiving compassionate care

Design outcomes

Primary

MeasureTime frame
Number of Days Care Provided in a Medical Settingend of study(about 24 months)
Total Number of Episodes of Serious Illnesses (Causing Death, Pediatric ICU Admission, and Hospital Stay > 7d).end of study(about 24 months)

Secondary

MeasureTime frameDescription
Cost Effectiveness of ETMend of study(about 24 months)this is defined strictly as a reduction in serious illnesses without an increase in health system costs, a decrease in health system costs without an increase in serious illnesses, or a reduction in both
Number of Hospital Admissions Due to All-Cause Infectionsend of study(about 24 months)
Average Numbers of Clinic Visitsend of study(about 24 months)
Average Total Number of Emergency Department Visitsend of study(about 24 months)
Average Number of Hospital Daysend of study(about 24 months)
Average Number of Pediatric Intensive Care Unit (PICU) Daysend of study(about 24 months)
Total Number of Deathsend of study(about 24 months)
Parent Ratings of Care Assessed Using the Consumer Assessment of Healthcare Providers and Systems Surveyend of study(about 24 months)This survey consists of 5 questions. The first 4 are scored from 1(never)-4(always) for a maximum score of 16 , a higher number indicating better care. The fifth question is scored form 0-10 a higher number indicating a better provider.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORRicardo A Mosquera, MD

The University of Texas Health Science Center, Houston

Baseline characteristics

Characteristic
Age, Continuous6.4 years
STANDARD_DEVIATION 3.99
Race/Ethnicity, Customized
Black
62 Participants
Race/Ethnicity, Customized
Hispanic
124 Participants
Race/Ethnicity, Customized
Non-Hispanic white
12 Participants
Race/Ethnicity, Customized
Other
39 Participants
Region of Enrollment
United States
124 participants
Sex: Female, Male
Female
50 Participants
Sex: Female, Male
Male
151 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
3 / 1246 / 130
other
Total, other adverse events
0 / 1240 / 130
serious
Total, serious adverse events
0 / 1240 / 130

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 15, 2026